VIMTA LABS
Back to Balance Sheet
|
VIMTA LABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹392 Cr | ₹358 Cr | ₹305 Cr | ₹273 Cr | ₹245 Cr |
What is the latest Total Liabilities ratio of VIMTA LABS ?
| Year | Total Liabilities |
|---|---|
| Mar2024 | ₹392 Cr |
| Mar2023 | ₹358 Cr |
| Mar2022 | ₹305 Cr |
| Mar2021 | ₹273 Cr |
| Mar2020 | ₹245 Cr |
How is Total Liabilities of VIMTA LABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹392 Cr | 9.56 | |
| Mar2023 | ₹358 Cr | 17.33 | |
| Mar2022 | ₹305 Cr | 11.61 | |
| Mar2021 | ₹273 Cr | 11.47 | |
| Mar2020 | ₹245 Cr | - | |
Compare Total Liabilities of peers of VIMTA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VIMTA LABS | ₹2,583.2 Cr | -1% | 0.9% | 34.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
VIMTA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VIMTA LABS | -1% |
0.9% |
34.3% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses